Moreover, dinaciclib shows anticancer efficacy in orthotopic xenograft mouse models derived from two NB cell lines and markedly decreases tumor development in the TH-MYCN transgenic NB mouse model [33]. This evidence concerns the gene MYCN and neuroblastoma.